
Migraines are estimated to affect around 15% of the world's population. In Canada, at least 2.6 million adult women and nearly one million men experience migraine. Every year about 3% of people who have migraine find their attacks increasing in frequency to 15 days a month or more — what is called chronic migraine. Injectable muscle-relaxing treatment is one of the preventive options used for chronic migraine in adults. It is a prescription treatment, and Canadian regulations don't permit us to discuss specific prescription products in public material, so that conversation happens at your assessment.

Temporomandibular disorder (TMD) is a collective term for a group of conditions involving the temporomandibular joint (TMJ), the muscles of chewing, and the surrounding structures. The prevalence of adults requiring treatment for TMD is estimated at about 16%, and is higher among women than among men. Injectable muscle-relaxing treatment can be used to reduce activity in the muscles of chewing as part of managing TMD.

Hyperhidrosis, or excessive sweating, is reported to affect approximately 3% of the Canadian population. Injectable treatment works by interrupting the nerve signals that stimulate the sweat glands. Published data report around a 75% reduction in symptoms, along with improvements in emotional and physical wellbeing and fewer limitations on day-to-day activity.

A hypertrophied trapezius muscle can be both a therapeutic problem, affecting mobility and quality of life, and an aesthetic one. Injectable muscle-relaxing treatment is used to reduce contractility in the muscle, which softens its bulk and can ease the associated symptoms. Improvement is usually reported around six to eight weeks after treatment.

Scars may not only be visible, they can also cause pain, itch and other forms of discomfort. Injectable muscle-relaxing treatment is an emerging approach in aesthetic medicine used to help reduce the visibility and the discomfort of hypertrophic scars. Outcomes are generally better for scars less than 12 months old.

Rosacea is a chronic skin condition that tends to recur and can be stubborn to treat, and its visible effects can affect confidence and quality of life. Injectable treatment has been used to reduce facial redness, flushing and the symptoms that accompany them, by reducing sweat gland activity and sebum production and constricting small blood vessels.
Please reach us at info@thewelle.ca if you cannot find an answer to your question.
The medication may be the same but the purpose is not. Therapeutic injections are used to treat a medical problem rather than to change how something looks, and that changes the assessment, the dosing, the documentation and often the treatment interval. It also means the conversation starts with your symptoms and your history rather than with your goals for your appearance.
Some plans cover some therapeutic indications and many do not, and the only way to know is to ask your insurer directly with the specific code and indication. We can tell you what we are treating and provide a receipt; we cannot tell you what your plan will accept.
Not immediately. Effect builds over one to two weeks, so judging it in the first few days will mislead you in both directions. We book a follow-up specifically so that we are assessing at the right point rather than guessing, and so that dose can be adjusted based on what actually happened rather than what was expected to.
No. As a nurse practitioner Jennifer can assess, diagnose and prescribe within her scope, so you can book an assessment directly. If what you need sits outside that scope, you will be told so and pointed somewhere appropriate rather than treated anyway.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.